IP Library Granted Patent US 7,049,289
Granted Patent B1
US 7,049,289 · App. 09/674,616 · Granted May 23, 2006

Labelled glutamine and lysine analogues

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,049,289
App. No.
09/674,616
Granted
May 23, 2006
Kind
B1
Abstract

Synthetic analogues of lysine and glutamine are provided which function as substrates for the fibrin-stabilising enzyme Factor XIIIa even when labelled with a detectable moiety. The use of suitable protecting groups provides compounds which possess reduced susceptibility to in vivo metabolism especially by peptidases, and are hence useful agents for the diagnosis of thrombosis, embolism, atherosclerosis, inflammation or cancer.

Claims (26)

1. A compound of formula:

Y—(CR 2 ) n X—NHJ

where:

X is C═O or CR 2 ;

n is an integer of value 1 to 6;

Y is R 1 R 2 CR— where one of R 1 and R 2 is —NH(B) p Z 1 and the other is —CO(B) q Z 2 where

p and q are integers of value 0 to 30, and

each B is independently chosen from Q or an amino acid residue,

where Q is a cyclic peptide;

Z 1 and Z 2 are metal complexing agents (L) or other protecting groups, which are biocompatible groups which inhibit or suppress in vivo metabolism of the peptide;

J and each R are independently chosen from H, C 1-4 alkyl, C 1-4 alkenyl, C 1-4 alkynyl, C 1-4 alkoxyalkyl or C 1-4 hydroxyalkyl;

with the proviso that:

(i) when X is CR 2 , then Z 2 is a metal complexing agent (L);

(ii) at least one of R 1 and R 2 bears at least one detectable moiety suitable for diagnostic imaging of the human body;

(iii) R 1 and R 2 include one or more of the peptide sequence consisting of NQEQVSPYTLLKG (SEQ ID NO: 2), which is a peptide fragment of α 2 -antiplasmin.

2. The compound of claim 1 where J is H.

3. The compound of claim 2 of formula:

Y—(CR 2 ) x —(CH 2 ) 2 CONH 2 or Y—(CR 2 ) y —(CH 2 ) 4 NH 2

where x is an integer of value 0 to 4, and y is an integer of value 0 to 3.

4. The compound of claim 1 where at least one of Z 1 and Z 2 is a metal complexing agent.

5. The compound of claim 4 where Z 2 is a metal complexing agent and Z 1 is not a metal complexing agent.

6. A metal complex of the compound of claim 4 .

7. The metal complex of claim 6 where the metal is a radiometal.

8. The radiometal complex of claim 7 where the radiometal is 99m Tc.

9. A preparation for human administration comprising the compound of claim 1 .

10. A kit comprising the compound of claim 1 useful in the preparation of metal complexes.

Assignments (3)
CHANGE OF NAME Recorded Jan 31, 2006
From: NYCOMED AMERSHAM PLC
To: GE HEALTHCARE LIMITED
Reel/Frame 017222/0874 →
CHANGE OF NAME Recorded Nov 13, 2003
From: NYCOMED AMERSHAM PLC
To: AMERHSAM PLC
Reel/Frame 014122/0834 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 18, 2000
From: STOREY, ANTHONY E.; GIBSON, ALEX; CHAMPION, SUSAN; GUILBERT, BENEDICTE; WILSON, IAN A.; MENDIZABEL, MARIVI; KNOX, PETER
To: NYCOMED AMERSHAM, PLC
Reel/Frame 011378/0619 →